Fuzhong Medical High-Tech, formerly known as Nanjing New Technology Application Research Institute Co. Ltd., belongs to Fuzhong Group which is one of the top 500 enterprises and national high and new technology enterprise. With abundant financial resources, formidable marketing team, top-end sale channels, good reputation and abundant products, Fuzhong Medical Hi-Tech owns 8 subsidiary companies and 46 offices in first-tier cities including Beijing, Shanghai and Guangzhou. We have more than 1000 employees, in which 30% with master degree or above and 10% with doctor degree or above. Presently, Fuzhong Medical Hi-Tech has already developed into International renowned large-scale medical equipment enterprise in researching, developing, manufacturing and selling.Fuzhong Medical Hi-Tech is the only strategic partner with National Ministry of Health and China Primary Health Care Foundation on several medical equipments including tumor coagulation equipment, varicose veins remedial equipment and remote patient monitoring system. Since 2010, Fuzhong Medical Hi-Tech cooperated with National Ministry of Health to launch the clinical research topic of “Intratumor Target Immunity Radiotherapy Applied Together with Microwave Ablation”. In the course of this research, the self-owned intellectual property rights product, known as New Generation of Computer Controlled Microwave Tumor Remedial Equipment, has been applied in over 100 first rate hospitals including 301 Hospital, 303 Hospital, Shanghai Huashang Hospital, Shanghai Renji Hospital and General Hospital of Guangzhou Military Command of PLA.Fuzhong Medical Hi-Tech aims to be the front-runner in the industry of medical equipment and will realize going public in 2014.
